The Labeled Streptavidin-Biotin Technique, often referred to in English as the Labeled Streptavidin-Biotin Method or Labeled Streptavidin-Biotin System, is a cornerstone technology in molecular detection, immunoassays, and histochemistry. This article provides a comprehensive overview of its principle, key components, applications, and advantages to fully address your inquiries.
It is an ultra-sensitive detection and amplification system based on the nearly irreversible non-covalent interaction between streptavidin (or avidin) and biotin (Vitamin B7). This binding is one of the strongest in nature (Kd ≈ 10⁻¹⁵ M), providing exceptional specificity and stability. In the “labeled” version, the streptavidin molecule itself is conjugated to a detectable marker (label), such as:
This direct conjugation allows for straightforward and powerful detection of a target molecule.
The technique typically involves a multi-step process, with the most common format being the Labeled Streptavidin-Biotin (LSAB) method for immunohistochemistry (IHC) or ELISA:
This cascade results in the accumulation of many label molecules at the site of the target antigen, enabling highly sensitive detection.
This technique is a workhorse in biomedical research and diagnostics:
You may encounter these related terms, which are specific implementations of the core concept:
In modern practice, streptavidin is strongly preferred over avidin due to its near-neutral isoelectric point, which results in much lower non-specific electrostatic binding to tissues and thus lower background noise.